Education
About Us
Working with TipRanks
Follow Us
Irhythm Technologies (IRTC)
NASDAQ:IRTC
IRTC Stock Chart & Stats
Day’s Range― - ―
52-Week Range$55.92 - $172.59
Previous CloseN/A
Volume94.23K
Average Volume (3M)490.98K
Market Cap
$5.40B
Enterprise Value$5.11B
Total Cash (Recent Filing)$545.54M
Total Debt (Recent Filing)$734.74M
Price to Earnings (P/E)―
Beta0.84
Next Earnings
Oct 30, 2025EPS Estimate
-0.33Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.44
Shares Outstanding32,127,760
10 Day Avg. Volume468,852
30 Day Avg. Volume490,982
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.95
Enterprise Value/Revenue7.78
Enterprise Value/Gross Profit11.15
Enterprise Value/Ebitda-78.15
Forecast
1Y Price Target
$184.64Price Target Upside8.75% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering12
Bulls Say, Bears Say
Bulls Say
Growth MomentumRecent momentum in the company's growth is expected to continue, giving confidence in sustained performance.
Market AdoptionLarge accounts are adopting all Zio services faster than expected, indicating strong demand.
Product InnovationThe upcoming launch of Zio MCT, a next-gen product in the mobile cardiac telemetry market, is expected to provide significant advantages over the existing Zio AT.
Bears Say
Market Expansion ChallengesThere are still many accounts to sign, with significant opportunities anticipated in the near future.
Regulatory RisksRisk factors include potential delays in Zio MCT, market expansion, and issues with FDA or DOJ resolutions, which could impact the growth trajectory.
Irhythm Technologies News
IRTC FAQ
What was Irhythm Technologies’s price range in the past 12 months?
Irhythm Technologies lowest stock price was $55.92 and its highest was $172.59 in the past 12 months.
What is Irhythm Technologies’s market cap?
Irhythm Technologies’s market cap is $5.40B.
When is Irhythm Technologies’s upcoming earnings report date?
Irhythm Technologies’s upcoming earnings report date is Oct 30, 2025 which is in 62 days.
How were Irhythm Technologies’s earnings last quarter?
Irhythm Technologies released its earnings results on Jul 31, 2025. The company reported -$0.44 earnings per share for the quarter, beating the consensus estimate of -$0.492 by $0.052.
Is Irhythm Technologies overvalued?
According to Wall Street analysts Irhythm Technologies’s price is currently Undervalued.
Does Irhythm Technologies pay dividends?
Irhythm Technologies does not currently pay dividends.
What is Irhythm Technologies’s EPS estimate?
Irhythm Technologies’s EPS estimate is -0.33.
How many shares outstanding does Irhythm Technologies have?
Irhythm Technologies has 32,127,760 shares outstanding.
What happened to Irhythm Technologies’s price movement after its last earnings report?
Irhythm Technologies reported an EPS of -$0.44 in its last earnings report, beating expectations of -$0.492. Following the earnings report the stock price went up 17.684%.
Which hedge fund is a major shareholder of Irhythm Technologies?
Currently, no hedge funds are holding shares in IRTC
Irhythm Technologies Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$184.64 (8.75% Upside)
$184.64 (8.75% Upside)
Blogger Sentiment
Bullish
IRTC Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 301.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $1.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 3.6%
Last 30 Days ▲ 2.8%
Last 30 Days ▲ 2.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
149.87%
12-Months-Change
Fundamentals
Return on Equity
-91.13%
Trailing 12-Months
Asset Growth
4.88%
Trailing 12-Months
Company Description
Irhythm Technologies
iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
IRTC Company Deck
IRTC Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a strong positive sentiment, with significant revenue growth, strategic partnerships, and international expansion contributing to the optimism. While there are some challenges related to FDA remediation and potential tariff impacts, the overall outlook remains robust due to effective execution and innovative initiatives.View all IRTC earnings summariesIRTC Stock 12 Month Forecast
Average Price Target
$184.64
▲(8.75% Upside)
Technical Analysis
Ownership Overview
1.86% Insiders
38.86% Mutual Funds
0.25% Other Institutional Investors
43.13% Public Companies and
Individual Investors